Cargando…

Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

BACKGROUND: Among rare channelopathies BrS patients are at high risk of sudden cardiac death (SCD). SCN5A mutations are found in a quarter of patients. Other rare gene mutations including SCN1B have been implicated to BrS. Studying the human cellular phenotype of BrS associated with rare gene mutati...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Battrawy, Ibrahim, Müller, Jonas, Zhao, Zhihan, Cyganek, Lukas, Zhong, Rujia, Zhang, Feng, Kleinsorge, Mandy, Lan, Huan, Li, Xin, Xu, Qiang, Huang, Mengying, Liao, Zhenxing, Moscu-Gregor, Alexander, Albers, Sebastian, Dinkel, Hendrik, Lang, Siegfried, Diecke, Sebastian, Zimmermann, Wolfram-Hubertus, Utikal, Jochen, Wieland, Thomas, Borggrefe, Martin, Zhou, Xiaobo, Akin, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839339/ https://www.ncbi.nlm.nih.gov/pubmed/31737628 http://dx.doi.org/10.3389/fcell.2019.00261

Ejemplares similares

A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells
por: Zhong, Rujia, et al.
Publicado: (2022)

Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene‐edited human‐induced pluripotent stem cell‐derived cardiomyocytes and preclinical drug screening
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2021)

TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes
por: Sattler, Katherine, et al.
Publicado: (2021)

Novel insights in the pathomechanism of Brugada syndrome and fever‐related type 1 ECG changes in a preclinical study using human‐induced pluripotent stem cell‐derived cardiomyocytes
por: Li, Yingrui, et al.
Publicado: (2023)

Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy
por: Buljubasic, Fanis, et al.
Publicado: (2020)

Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes
por: Sattler, Katherine, et al.
Publicado: (2019)

Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
por: Yücel, Gökhan, et al.
Publicado: (2017)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Huang, Mengying, et al.
Publicado: (2021)

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Zhao, Zhihan, et al.
Publicado: (2018)

Modeling Short QT Syndrome Using Human‐Induced Pluripotent Stem Cell–Derived Cardiomyocytes
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Implantable cardioverter‐defibrillator in Brugada syndrome: Long‐term follow‐up
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2019)

Arrhythmic events in Brugada syndrome patients induced by fever
por: Roterberg, Gretje, et al.
Publicado: (2019)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
por: Lan, Huan, et al.
Publicado: (2020)

Variable Brugada syndrome phenotype severity in a dish: dreams meet reality
por: El-Battrawy, Ibrahim, et al.
Publicado: (2023)

Lipopolysaccharide Modifies Sodium Current Kinetics through ROS and PKC Signalling in Induced Pluripotent Stem-Derived Cardiomyocytes from Brugada Syndrome Patient
por: Liao, Zhenxing, et al.
Publicado: (2022)

Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells
por: Li, Yingrui, et al.
Publicado: (2022)

Incidence, recurrence and management of electrical storm in Brugada syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2022)

Regulation of Ion Channel Function in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes by Cancer Cell Secretion Through DNA Methylation
por: Zhong, Rujia, et al.
Publicado: (2022)

Identification of SCN5a p.C335R Variant in a Large Family with Dilated Cardiomyopathy and Conduction Disease
por: Sedaghat-Hamedani, Farbod, et al.
Publicado: (2021)

Dopamine D1/D5 Receptor Signaling Is Involved in Arrhythmogenesis in the Setting of Takotsubo Cardiomyopathy
por: Huang, Mengying, et al.
Publicado: (2022)

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: El-Battrawy, Ibrahim, et al.
Publicado: (2016)

Antiarrhythmic Effects of Vernakalant in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Short QT Syndrome Type 1
por: Xu, Qiang, et al.
Publicado: (2022)

Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes
por: Kleinsorge, Mandy, et al.
Publicado: (2020)

Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
por: Yuecel, Goekhan, et al.
Publicado: (2023)

Association of a congenital long QT syndrome type 1 with Takotsubo cardiomyopathy
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2016)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Simultaneous Non‐Invasive Epicardial and Endocardial Mapping in Patients With Brugada Syndrome: New Insights Into Arrhythmia Mechanisms
por: Rudic, Boris, et al.
Publicado: (2016)

Age related differences and outcome of patients with Takotsubo syndrome
por: Huseynov, Aydin, et al.
Publicado: (2017)

Short‐term and long‐term incidence of stroke in Takotsubo syndrome
por: El‐Battrawy, Ibrahim, et al.
Publicado: (2018)

Short- and Long-Term Incidence of Thromboembolic Events in Takotsubo Syndrome as Compared With Acute Coronary Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells
por: Fan, Xuehui, et al.
Publicado: (2022)

SCN5A Mutation Type and a Genetic Risk Score Associate Variably With Brugada Syndrome Phenotype in SCN5A Families
por: Wijeyeratne, Yanushi D., et al.
Publicado: (2020)

SCN1B gene variants in Brugada Syndrome: a study of 145 SCN5A-negative patients
por: Ricci, Maria Teresa, et al.
Publicado: (2014)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020)

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation
por: Li, Wener, et al.
Publicado: (2020)

In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant
por: Doisne, Nicolas, et al.
Publicado: (2021)

Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect
por: Veltmann, Christian, et al.
Publicado: (2016)

Takotsubo syndrome and cardiac implantable electronic device therapy
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)

Long-Term Follow-Up of Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
por: Veith, Michael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b70sdtrhr8nld01klff642ok91